Effectiveness of 5-Pyrrolidone-2-Carboxylic Acid and Copper Sulphate (Pirometaxine) in Cold Dry Air Induced Rhinitis With or Without Viral Superinfection
Journal Title: Pulmonary Research and Respiratory Medicine – Open Journal - Year 2015, Vol 2, Issue 3
Abstract
Introduction: Exposure to cold dry air can determine rhinitis-like symptoms. 5-Pyrrolidone-2-Carboxylic acid (PCA) and Copper Sulphate (CS) showed antiviral and osmoprotectant effect. Aim of this study is evaluation of effectiveness of 5-Pyrrolidone-2-Carboxylic acid (PCA) and Copper Sulphate pentahydrate (CS) (Pirometaxine) association in the treatment of cold dry air rhinitis with or without viral infection. Methods: Fifty consecutive adult patients affected by cold dry air rhinitis with or without viral/bacterial infection were enrolled in this prospective observational study and treated with pyroglutamic acid (PCA) plus copper sulphate (CS) (pirometaxine). All patients underwent an objective evaluation with optic fiber endoscopy and symptoms assessment at time of enrolment, after 3 and 7 days of treatment. Results: All symptoms scores decreased at 3 and 7 days with a mean Total Symptoms Score of 5.98±2.22 and 1.30±1.23, respectively. Twenty-seven patients (54%) reached a Total Symptoms Score of zero after 7 days. Median number of days until healing was 6. Only 18% of cases had turbinate hypertrophy and 10% nasal mucosa hyperaemia after 7 days. Main side effects were nasal itch in 4 cases (8%) and nasal burning in one case (2%). Conclusions: The association of 5-Pyrrolidone-2-carboxylic acid and copper sulphate (pirometaxine) represent a safe treatment for CDA-induced rhinitis with or without viral infection, with few side effects. Clinical importance of this therapy will be better understood with further studies, comparing results to those observed in a control group.
Authors and Affiliations
Giuseppe Riva
Keywords
Related Articles
- EP ID EP550116
- DOI 10.17140/PRRMOJ-2-115
- Views 127
- Downloads 0
Comparison of Next-Generation Sequencing Platforms for Clinical Testing of Non-Small Cell Lung Cancer
Personalized treatment of lung cancer using therapies that target activating oncogenic mutations such as EGFR and ALK has become the standard of care. Current molecular testing is routinely performed for single genes and...
Microarray Analysis Identifies Pathways in Progression of Early Stage Lung Adenocarcinoma: The Importance of Focal Adhesion and ECM-Receptor Interactions
Recurrence after lung cancer surgery is high, even among Non-Small Cell Lung Cancer (NSCLC) adenocarcinoma patients diagnosed early as Stage I, where there has been no spread to lymph nodes. Understanding the biological...
Biomarkers for Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (COPD): What is the Role of microRNAs?
Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous respiratory disease characterized by a progressive, not fully reversible airflow limitation associated with an abnormal inflammatory response of the lungs t...
Tuberculosis in Pregnancy: Delayed Diagnosis, Lost Lives
Tuberculosis still remains an important global health disease, killing many people annually. Yet it is a preventable cause of death. Maternal mortality rates due to tuberculosis and HIV/AIDS in Sub-Saharan Africa make up...
Cultural Differences in Illness Perception and Adherence to Treatment of Cystic Fibrosis Patients
Background: Patients with Cystic Fibrosis (CF) have a complex treatment regimen which poses emotional, social and economic burden. Adherence to treatment may be influenced by the patient’s own beliefs about the disease,...